These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39135516)

  • 1. Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review.
    Ageeb SA; Abdelmoghith A; ElGeed H; Awaisu A; ElMansor A; Owusu YB
    Pharmacoepidemiol Drug Saf; 2024 Aug; 33(8):e5879. PubMed ID: 39135516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database.
    Vinogradova Y; Coupland C; Brindle P; Hippisley-Cox J
    BMJ; 2016 Jun; 353():i3305. PubMed ID: 27353261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France.
    Giral P; Neumann A; Weill A; Coste J
    Eur Heart J; 2019 Nov; 40(43):3516-3525. PubMed ID: 31362307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
    Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins in Older Danes: Factors Associated With Discontinuation Over the First 4 Years of Use.
    Thompson W; Jarbøl DE; Haastrup P; Nielsen JB; Pottegård A
    J Am Geriatr Soc; 2019 Oct; 67(10):2050-2057. PubMed ID: 31335968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin discontinuation in high-risk patients: a systematic review of the evidence.
    Gomez Sandoval YH; Braganza MV; Daskalopoulou SS
    Curr Pharm Des; 2011 Nov; 17(33):3669-89. PubMed ID: 22074437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for (Discontinuation of) Statin Treatment in Older Adults: Review of Guidelines.
    van der Ploeg MA; Floriani C; Achterberg WP; Bogaerts JMK; Gussekloo J; Mooijaart SP; Streit S; Poortvliet RKE; Drewes YM
    J Am Geriatr Soc; 2020 Feb; 68(2):417-425. PubMed ID: 31663610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin Discontinuation and Cardiovascular Events Among Older People in Denmark.
    Thompson W; Morin L; Jarbøl DE; Andersen JH; Ernst MT; Nielsen JB; Haastrup P; Schmidt M; Pottegård A
    JAMA Netw Open; 2021 Dec; 4(12):e2136802. PubMed ID: 34854906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented.
    Pate A; Elliott RA; Gkountouras G; Thompson A; Emsley R; van Staa T
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):644-652. PubMed ID: 32394495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.
    Bai JW; Boulet G; Halpern EM; Lovblom LE; Eldelekli D; Keenan HA; Brent M; Paul N; Bril V; Cherney DZ; Weisman A; Perkins BA
    Cardiovasc Diabetol; 2016 Jan; 15():14. PubMed ID: 26809442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin adherence is lower in primary than secondary prevention: A national follow-up study of new users.
    Sigglekow F; Horsburgh S; Parkin L
    PLoS One; 2020; 15(11):e0242424. PubMed ID: 33211724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses.
    Cai T; Abel L; Langford O; Monaghan G; Aronson JK; Stevens RJ; Lay-Flurrie S; Koshiaris C; McManus RJ; Hobbs FDR; Sheppard JP
    BMJ; 2021 Jul; 374():n1537. PubMed ID: 34261627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease.
    Byrne P; Cullinan J; Murphy C; Smith SM
    BMJ Open; 2018 Feb; 8(2):e018524. PubMed ID: 29439070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence With Statins in Primary Prevention of Cardiovascular Disease: Findings From a Cohort of Spanish Workers.
    Malo S; Aguilar-Palacio I; Feja C; Menditto E; Lallana MJ; Andrade E; Casasnovas JA; Rabanaque MJ
    Rev Esp Cardiol (Engl Ed); 2018 Jan; 71(1):26-32. PubMed ID: 28473266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Cantor A; Dana T; Wagner J; Ahmed AY; Fu R; Ferencik M
    JAMA; 2022 Aug; 328(8):754-771. PubMed ID: 35997724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients who discontinued statin treatment: a protocol for cohort study using primary care data.
    Vinogradova Y; Coupland C; Brindle P; Hippisley-Cox J
    BMJ Open; 2015 Oct; 5(10):e008701. PubMed ID: 26493458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
    Laleman N; Henrard S; van den Akker M; Goderis G; Buntinx F; Van Pottelbergh G; Vaes B
    BMC Cardiovasc Disord; 2018 Nov; 18(1):209. PubMed ID: 30400778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
    Nanna MG; Navar AM; Wang TY; Mi X; Virani SS; Louie MJ; Lee LV; Goldberg AC; Roger VL; Robinson J; Peterson ED
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29739801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk stratification analysis of atherosclerotic cardiovascular disease events post-statin discontinuation in patients who underwent sleeve gastrectomy or Roux-en-Y gastric bypass bariatric/metabolic surgeries.
    Alsuhibani AA; Al-Kadi A; Wigle PR; Guo JJ; Lin AC; Rao MB; Hincapie AL
    Surgery; 2024 Sep; 176(3):597-604. PubMed ID: 38902126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease.
    Hope HF; Binkley GM; Fenton S; Kitas GD; Verstappen SMM; Symmons DPM
    PLoS One; 2019; 14(1):e0201196. PubMed ID: 30653535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.